Acorda: Q3 Earnings Snapshot
Acorda: Q3 Earnings Snapshot
By AP News
Published - Nov 01, 2022, 04:57 PM ET
Last Updated - Jun 23, 2023, 10:15 PM EDT
PEARL RIVER, N.Y. (AP) _ Acorda Therapeutics Inc. (ACOR) on Tuesday reported a loss of $13.9 million in its third quarter.
The Pearl River, New York-based company said it had a loss of 57 cents per share.
The drugmaker posted revenue of $33.5 million in the period.
Acorda expects full-year revenue in the range of $116 million to $119.7 million.
In the final minutes of trading on Tuesday, the company's shares hit 80 cents. A year ago, they were trading at $4.18.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a ACOR">Zacks stock report on ACOR at https://www.zacks.com/ap/ACOR
